SCHEMBL4297801

SCHEMBL4297801

CC(Cc1nc2c(nc(-c3ccc(Cl)cc3)n2C)c(=O)[nH]1)C(F)(F)F

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE9A O76083 2/20 0.48
PDE1C Q14123 1/20 0.48
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
ALDH1A1 P00352 4/20 0.39
HPGD P15428 3/20 0.39
KDM4E B2RXH2 2/20 0.39
PKM P14618 1/20 0.39
DHFR P00374 2/20 0.38
MAPT P10636 1/20 0.36
LMNA P02545 1/20 0.35
GAA P10253 1/20 0.35
RECQL P46063 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ADORA3 P0DMS8 1/20 0.34
ADORA2A P29274 1/20 0.34
ADORA1 P30542 1/20 0.34
TRPV1 Q8NER1 1/20 0.34
PTGS1 P23219 1/20 0.34
PTGS2 P35354 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4296187 1.00 PDE9A (0.48) PDE9APDE1CMEN1KMT2AALDH1A1
SCHEMBL4295752 0.90 MEN1 (0.42) PDE9APDE1CMEN1KMT2AALDH1A1
SCHEMBL4290620 0.88 PDE9A (0.45) PDE9APDE1CMEN1KMT2AALDH1A1
SCHEMBL4290740 0.88 MEN1 (0.42) PDE9APDE1CMEN1KMT2AALDH1A1
SCHEMBL4769038 0.81 MEN1 (0.44) MEN1KMT2AALDH1A1HPGDKDM4E
SCHEMBL4288221 0.80 HPGD (0.37) PDE9APDE1CKMT2AALDH1A1HPGD
SCHEMBL4776971 0.80 MEN1 (0.46) MEN1KMT2AALDH1A1HPGDKDM4E
SCHEMBL4775804 0.79 MEN1 (0.46) MEN1KMT2AALDH1A1HPGDKDM4E
SCHEMBL4774152 0.78 PARP1 (0.38) PDE9APDE1CALDH1A1HPGDKDM4E
SCHEMBL4290696 0.78 ALDH1A1 (0.38) PDE9APDE1CMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2061470-A2 HALOALKYL-SUBSTITUTED PYRIMIDINONE DERIVATIVES Neurogen Corporation (US) 2009-05-27 EP claimed
WO-2008024433-A2 HALOALKYL-SUBSTITUTED PYRIMIDINONE DERIVATIVES NEUROGEN CORPORATION (US) 2008-02-28 WO claimed
EP-1881988-A1 2,3-SUBSTITUTED FUSED BICYCLIC PYRIMIDIN-4(3H)-ONES MODULATING THE FUNCTION OF THE VANILLOID-1 RECEPTOR (VR1) MERCK SHARP & DOHME LTD. (GB) 2008-01-30 EP disclosed
WO-2006122200-A1 2,3-SUBSTITUTED FUSED BICYCLIC PYRIMIDIN-4(3H)-ONES MODULATING THE FUNCTION OF THE VANILLOID-1 RECEPTOR (VR1) MERCK SHARP & DOHME LIMITED (GB) 2006-11-16 WO disclosed